291 related articles for article (PubMed ID: 1532032)
1. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
2. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
[TBL] [Abstract][Full Text] [Related]
3. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
4. The anti-emetic activity of GK-128 in Suncus murinus.
Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
[TBL] [Abstract][Full Text] [Related]
5. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
6. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
7. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.
Yoshida N; Omoya H; Kato S; Ito T
Eur J Pharmacol; 1992 Jun; 216(3):435-40. PubMed ID: 1425931
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Ozaki A; Sukamoto T
Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
[TBL] [Abstract][Full Text] [Related]
10. Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets.
Minami M; Endo T; Tamakai H; Ogawa T; Hamaue N; Hirafuji M; Monma Y; Yoshioka M; Hagihara K
Eur J Pharmacol; 1997 Mar; 321(3):333-42. PubMed ID: 9085045
[TBL] [Abstract][Full Text] [Related]
11. Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
Kamato T; Miyata K; Ito H; Yuki H; Yamano M; Honda K
Jpn J Pharmacol; 1991 Nov; 57(3):387-95. PubMed ID: 1813664
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
13. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of AS-9705, a novel benzotriazolecarboxamide derivative, as a gastroprokinetic agent with potent anti-emetic activity.
Yoshikawa T; Mine Y; Morikage K; Yoshida N
Arzneimittelforschung; 2003; 53(2):98-106. PubMed ID: 12642965
[TBL] [Abstract][Full Text] [Related]
15. Action of anti-tussive drugs on the emetic reflex of Suncus murinus (house musk shrew).
Chan SW; Rudd JA; Lin G; Li P
Eur J Pharmacol; 2007 Mar; 559(2-3):196-201. PubMed ID: 17254564
[TBL] [Abstract][Full Text] [Related]
16. Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
Yoshikawa T; Yoshida N; Oka M
Eur J Pharmacol; 2001 Nov; 431(3):361-4. PubMed ID: 11730730
[TBL] [Abstract][Full Text] [Related]
17. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
Gylys JA; Wright RN; Nicolosi WD; Buyniski JP; Crenshaw RR
J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet.
Grélot L; Le Stunff H; Milano S; Blower PR; Romain D
J Pharmacol Exp Ther; 1996 Oct; 279(1):255-61. PubMed ID: 8859001
[TBL] [Abstract][Full Text] [Related]
19. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
[TBL] [Abstract][Full Text] [Related]
20. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]